Genincode

Genincode Dividend

Dividend of Genincode (GENI.L) as of Nov 13, 2026.

Dividend

0.00GBP

Last updated:

How much dividend does Genincode 2026 pay?

According to the latest status from November 2026, Genincode paid a total of 0.00 GBP per share in dividends within the last 12 months. With the current Genincode price of 0.01 GBP, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical Genincode Dividends

Historical Genincode Dividends
PaydateDividend

The Genincode Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2022
0.00 GBP
Jan 1, 2023
0.00 GBP
Jan 1, 2024
0.00 GBP
Jan 1, 2025
0.00 GBP
Jan 1, 2026 (e)
0.00 GBP
Jan 1, 2027 (e)
0.00 GBP
Jan 1, 2028 (e)
0.00 GBP
Jan 1, 2029 (e)
0.00 GBP
The Genincode Dividend history
YEARDividendYoY
est0.00GBP—
est0.00GBP—
est0.00GBP—
est0.00GBP—
0.00GBP—
0.00GBP—
0.00GBP—
0.00GBP—
0.00GBP—
0.00GBP—
0.00GBP—

Is the Genincode Dividend Safe?

Genincode has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding Genincode's Dividend Distributions

Genincode’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Genincode's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Genincode's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Genincode’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Genincode Stock analysis

What does Genincode do? GENinCode Plc generates revenue through its genetic risk assessment products for cardiovascular disease, including Cardio Incode, Lipid Incode, Sudd Incode, Roca Test, Thrombo, and Thrombo Incode Reproductive Health. The company targets healthcare practitioners who use its genomic precision testing, combining polygenic technology, molecular testing, genotyping, sequencing, and AI bioinformatics to assess patient DNA risk. Its products integrate genetic and clinical data to provide predictive care strategies for cardiovascular disease prevention. The firm serves medical professionals seeking advanced tools for patient risk evaluation and treatment planning. The company's wholly owned subsidiaries, GENinCode S.L.U. and GENinCode U.S. INC., support its global operations in risk assessment and prevention services. GENinCode Plc's focus on cardiovascular disease risk assessment leverages AI-driven bioinformatics to deliver tailored preventative care solutions. Healthcare providers utilize its comprehensive testing suite to enhance clinical decision-making and patient outcomes in cardiovascular health management. Genincode is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genincode stock

Genincode paid dividends every year for the past 0 years.

Genincode is assigned to the 'Health' sector.

The dividends of Genincode are distributed in GBP.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — Genincode